BEAM
Price
$16.36
Change
-$0.49 (-2.91%)
Updated
Aug 29 closing price
Capitalization
1.66B
69 days until earnings call
CRSP
Price
$51.83
Change
-$1.22 (-2.30%)
Updated
Aug 29 closing price
Capitalization
4.71B
57 days until earnings call
Interact to see
Advertisement

BEAM vs CRSP

Header iconBEAM vs CRSP Comparison
Open Charts BEAM vs CRSPBanner chart's image
Beam Therapeutics
Price$16.36
Change-$0.49 (-2.91%)
Volume$1.9M
Capitalization1.66B
CRISPR Therapeutics AG
Price$51.83
Change-$1.22 (-2.30%)
Volume$1.59M
Capitalization4.71B
BEAM vs CRSP Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CRSP commentary
Sep 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and CRSP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 02, 2025
Stock price -- (BEAM: $16.36 vs. CRSP: $51.83)
Brand notoriety: BEAM and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 80% vs. CRSP: 46%
Market capitalization -- BEAM: $1.66B vs. CRSP: $4.71B
BEAM [@Biotechnology] is valued at $1.66B. CRSP’s [@Biotechnology] market capitalization is $4.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.25B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and CRSP are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • CRSP’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than CRSP.

Price Growth

BEAM (@Biotechnology) experienced а -1.68% price change this week, while CRSP (@Biotechnology) price change was -4.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.70%. For the same industry, the average monthly price growth was +20.59%, and the average quarterly price growth was +30.71%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 10, 2025.

CRSP is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (-0.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($4.71B) has a higher market cap than BEAM($1.66B). CRSP YTD gains are higher at: 31.682 vs. BEAM (-34.032). BEAM has higher annual earnings (EBITDA): -414.33M vs. CRSP (-533.5M). CRSP has more cash in the bank: 1.72B vs. BEAM (1.15B). BEAM has less debt than CRSP: BEAM (155M) vs CRSP (215M). BEAM has higher revenues than CRSP: BEAM (60.3M) vs CRSP (35M).
BEAMCRSPBEAM / CRSP
Capitalization1.66B4.71B35%
EBITDA-414.33M-533.5M78%
Gain YTD-34.03231.682-107%
P/E RatioN/AN/A-
Revenue60.3M35M172%
Total Cash1.15B1.72B67%
Total Debt155M215M72%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
79
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCRSP
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 5 days ago
78%
Momentum
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 5 days ago
82%
MACD
ODDS (%)
Bullish Trend 5 days ago
81%
Bearish Trend 6 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
85%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 19 days ago
80%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SIICX16.41-0.01
-0.06%
AlphaCentric Real Income C
EDICX11.18-0.04
-0.36%
Eaton Vance Global Income Builder C
SDGZX135.36-1.54
-1.12%
DWS Capital Growth R6
FAEGX20.55-0.27
-1.30%
Fidelity Advisor Equity Growth M
NLCAX53.22-0.71
-1.32%
Voya Large-Cap Growth A

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
-2.91%
CRSP - BEAM
67%
Closely correlated
-2.30%
NTLA - BEAM
64%
Loosely correlated
-2.11%
RXRX - BEAM
63%
Loosely correlated
-3.39%
SYRE - BEAM
58%
Loosely correlated
-1.38%
DNLI - BEAM
56%
Loosely correlated
-2.43%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-2.30%
RXRX - CRSP
68%
Closely correlated
-3.39%
BEAM - CRSP
67%
Closely correlated
-2.91%
NTLA - CRSP
64%
Loosely correlated
-2.11%
CRBU - CRSP
59%
Loosely correlated
-3.61%
PRME - CRSP
57%
Loosely correlated
-5.81%
More